Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Feasibility of ovarian stimulation with tamoxifen and oocyte/embryo freezing prior chemotherapy in breast cancer
2013-001981-40Phase 2Active
- Sponsor
- Institut Cancérologique de l'Ouest
- Start
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of tamoxifen in breast cancer, sponsored by Institut Cancérologique de l'Ouest. Primary endpoint: Number of oocytes and/or embryos per patient. Started Apr 2014; status: active.
02
Drugs
tamoxifen
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2013-001981-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001981-40.